The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.
Part of paid clinical trials in Fountain Valley, California.
- Sponsor
- Incyte Corporation
- Study ID
- NCT05696392
- Phase
- PHASE4
- Status
- Terminated
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- ruxolitinib cream — DRUGruxolitinib cream 1.5% will be applied twice daily as a thin film
Study Details
The purpose of the study is to evaluate the effect of ruxolitinib cream on sleep disturbances with participants with Atopic Dermatitis.
Key Dates
- Start date
- Mar 16, 2023
- Status verified
- Dec 2025
- Primary completion
- Jan 22, 2025
- Completion
- Jan 22, 2025
Study Design
- Enrollment
- 47 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Treatment Group: Ruxolitinibruxolitinib cream 1.5% will be applied twice daily (BID) as a thin film.
Primary Outcome Measure
Change From Baseline in Total Sleep Time (TST) as Measured by Ōura Ring Wearable Device at Week 8 [ Time Frame: Baseline; Week 8 ]
Locations (30)
Find similar trials in Fountain Valley, CA
By condition
By specialty
Related Studies
- Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis ResearchRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)Recruiting · Regeneron Pharmaceuticals · Boston, Massachusetts
- Skin Microbial Ecology in Atopic DermatitisRecruiting · University of Rochester · Rochester, New York
- Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 PolymorphismRecruiting · Boston Children's Hospital · Boston, Massachusetts